Patento informacija

EN | LT

LT - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form

EN - Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys

Tarptautinės patentų klasifikacijos indeksai (TPK)
(51)	INT.CL.	C07D 401/14
		A61K 31/506
		A61P 35/00

Europos patentas
(11)	Patento numeris	2535337
(13)	Dokumento rūšis	T
(96)	Europos patento paraiškos numeris	12160493.8
	Europos patento paraiškos padavimo data	2006-07-18
(97)	Europos patento paraiškos paskelbimo data	2012-12-19
(45)	Paskelbimo apie Europos patento išdavimą data	2017-08-23
(46)	Apibrėžties vertimo paskelbimo data

Prioriteto paraiškos
(30)	Numeris	Data	Šalis
	701405 P	2005-07-20	US
	716214 P	2005-09-12	US

Išradėjai
(72)	Manley, Paul W., CH Shieh, Wen-Chung, US Sutton, Paul Allen, US Karpinski, Piotr H., US Wu, Raeann, US Monnier, Stéphanie, FR Brozio, Jörg, CH

Savininkas
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT

Pavadinimas
(54)	Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form
	Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form